Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Drugs considered for COVID-19 can increase risk for dangerous arrhythmias

As some consider treating coronavirus patients with a combination of the malaria drug hydroxychloroquine and the antibiotic azithromycin, cardiologists are advising caution because both medications can increase the risk for dangerous abnormal heart rhythms.

2 Apr 2020

Scientists find important clues to vaccine in SARS-CoV-2 genome

A new research paper published by scientists at the University of Bristol who sequenced the genome of the SARS-CoV-2 virus, which is causing the worldwide COVID-19 illness, reveals some significant findings that could help researchers working on rolling out vaccines to stop the relentless march of the virus. The study was published online on the preprint site bioRxiv in April 2020.

2 Apr 2020

COVID-19 by the numbers

Numerical data sometimes reveal facts that are otherwise concealed within an onslaught of information from an overwhelming number of sources.

2 Apr 2020

Public health interventions will drive economic recovery from COVID-19

A major new study titled “Pandemics Depress the Economy, Public Health Interventions Do Not: Evidence from the 1918 Flu,” by MIT economist Emil Verner and others, and published as a working paper in the Social Science Research Network, puts the role of public health measures and financial welfare during public health crises into perspective.

2 Apr 2020

Can cats and dogs catch or spread COVID-19?

A recent report from Hong Kong that two dogs had tested positive for the novel coronavirus SARS-CoV-2 had pet owners in a tizzy. This was compounded by news that a cat owned by a COVID-19 patient had developed symptoms of the illness in Belgium – such as breathing trouble and diarrhea – a week after the owner tested positive. The cat’s vomit and feces were subsequently found to be positive for the viral genome.

2 Apr 2020

MIT launches new technique to mass manufacture disposable face shields

The shortage of personal protective equipment (PPE) available to healthcare professionals has become increasingly problematic as Covid-19 cases continue to surge.

2 Apr 2020

COVID-19: What the illness looks like

With increasing information about COVID-19 disease gathered first-hand, a more accurate picture of the clinical features is coming together.

2 Apr 2020

Promising vaccine patch candidate for COVID-19

In a breath of fresh air, scientists from the University of Pittsburgh School of Medicine reported that they had developed a potential new vaccine against the SARS-CoV-2 virus, which is causing the current COVID-19 pandemic. The vaccine has been tested in mice. When administered through a small patch only the size of a fingertip, the vaccine was found to generate protective neutralizing antibodies against the virus, in adequate quantities.

2 Apr 2020

AI to predict risk of an individual patient's need for ventilator

As coronavirus patients are hospitalized, it is difficult for doctors to predict which of them will require intensive care and a respirator. Many different factors come into play, some yet to be fully understood by doctors.

2 Apr 2020

KHN’s ‘What the Health?’: All coronavirus all the time

The medical and economic needs laid bare by the coronavirus pandemic are forcing some immediate changes to the U.S. health system. Congress, in its latest relief bill, provided $100 billion in funding for the hospital industry alone.

2 Apr 2020

Web portal provides information on how to decontaminate used N95 masks

As health workers and first responders in the United States try to stem a pandemic without adequate protective gear, health officials are forced to consider a stopgap - decontaminating and reusing N95 masks to shield those whose jobs expose them to the virus that causes COVID-19.

2 Apr 2020

Nanoneedle technology licensed for early detection of disease, biomarker discovery

A Boston-based startup company, NanoMosaic LLC, intends to commercialize a high-throughput, high-sensitivity platform for analyte detection developed at Harvard University.

2 Apr 2020

Pandemic-stricken cities have empty hospitals, but reopening them is difficult

As city leaders across the country scramble to find space for the expected surge of COVID-19 patients, some are looking at a seemingly obvious choice: former hospital buildings, sitting empty, right downtown.

2 Apr 2020

Penn State engineer developing point-of-care testing device to diagnose COVID-19

A point-of-care testing device that may help diagnose the novel coronavirus disease (COVID-19) is under development by Weihua Guan, assistant professor of electrical engineering in Penn State's College of Engineering.

2 Apr 2020

Patients with chronic liver disease need specific care during COVID-19

Currently, there are limited data on the impact of pre-existing liver disease and the course of SARS-CoV-2 infection, with many open questions.

2 Apr 2020

UIC participates in two clinical trials for COVID-19 treatments

The University of Illinois at Chicago is participating in two clinical trials for COVID-19 treatments.

2 Apr 2020

Biogazelle initiates large-scale testing of patient samples for SARS-CoV-2

Biogazelle NV, a CRO specialized in RNA analytics, has announced the initiation of large-scale testing of patient samples for SARS-CoV-2. Biogazelle is providing one of the multiple testing sites in a government-led consortium of pharma, biotech, IT and academia, alongside Janssen Pharmaceutica (J&J), GSK, UCB, UgenTec, MIPS and ThermoFisher.

2 Apr 2020

OXGENE and The Native Antigen Company Announce Collaboration to Increase COVID-19 Antigen Production for Diagnostic Kits and Vaccine Development

OXGENE™ and The Native Antigen Company today announced a collaboration to scale up production of SARS-CoV-2 (COVID-19) reagents.

2 Apr 2020

Study looks at Russian trolls that polarize vaccination efforts

There has always been controversy surrounding vaccines, but in the past, that was usually overridden by fear of the disease itself. The diseases vaccines prevent can be dangerous or even deadly. However, many anti-vaccination groups add to the confusion of people on the benefits of immunization against infectious diseases.

2 Apr 2020

Patients with hypertension, diabetes and heart disease more likely to die from COVID-19

As the coronavirus disease (COVID-19) evolves, important information emerges, thanks to studies and analyses undertaken by scientists and health experts. With more data available based on patients in actual healthcare settings, scientists have more information on how the virus affects the body and who are at most risk of the disease.

2 Apr 2020